AWM PHARMA
Timeline
7 events since 2024Filings
Financial
Establishments
Address
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 30 days before the deadline
2025
Equity above €200,000 equity €326,211 ▲94.4% With a profit in every financial year since 2024, equity grows to €326,211.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1005406780
Annual accounts 2024 filed PDFfull format · 30 days before the deadline
2024
Registered office moved from Woluwe-Saint-Lambert to BrusselsNew registered office: Rue de Flandre 4 bte2 à 1000 Bruxelles · Previous registered office: Galerie des Argousiers 13/407 à 1200 Woluwé-Saint-Lambert · General meeting of 02-09-20242 points ▸
- General meeting, 02-09-2024
- Registered-office move, Rue de Flandre 4 bte2 à 1000 Bruxelles
IncorporationFounding capital of €100,000, 120 shares, €2,500 paid up · Founder: WAHIB MOUSSA Asmaa (comparant) · Appointment: WAHIB MOUSSA Asmaa (director) · published on 01-02-20246 points ▸
- Founder, WAHIB MOUSSA Asmaa (comparant)
- Founding capital, €100,000, 120 shares
- WAHIB MOUSSA Asmaa holds 120 shares
- 120 shares
- Registered office clause, Galerie des Argousiers 13/407, 1200 Woluwe-Saint-Lambert
- Director appointment, WAHIB MOUSSA Asmaa (director (not named in the articles))
- The deed holds 4 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
AWM PHARMA was incorporated on 30 January 2024 as a private limited company by one natural person, with a starting capital of €100,000.12 The registered office was moved to Brussels in 2024.3 Since 2024, WAHIB MOUSSA Asmaa has served as director.4